We are Antioxidant 168 CAS:31570-04-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
SPECIFICATIONS AND PHYSICAL CHARACTERISTICS
TEST | UNIT | SPECIFICATION |
APPEARANCE | WHITE CRYSTALINE POWDER | |
ASSAY | % | 99.00MIN |
VOLATILES | % | 0.30MAX |
MELTING POINT | ℃ | 183.00-187.00 |
CLARITY | CLEAR | |
TRANSMITTANCE | ||
425nm | % | 96.00MIN |
500nm | % | 98.00MIN |
CONTENT OF DTBP | % | 0.20MAX |
ACIDITY | mgKOH/g | 0.25MAX |
HYDROLYZATION | H | 14MIN |
TGA 265℃ 5% 271℃ 10% 315℃ 50%
PRODUCT FEATURES AND APPLICATIONS
AN 168 is secondary antioxidant with excellent resistance to extraction by water, low volatility and high heat stability. It reacts during processing with hydroperoxides formed by autoxidation of polymers preventing process induced degradation and extending the performance of primary antioxidants
AN 168 has better synergist effort with Primary Antioxidant AN 1010.
AN 168 is of good compatibility with most Polyolefin like ABS,PC,PVC,PU, Polyester, PP,PS PBT,PET,PMMA,TPE and etc
PACKAGE
20KG Bag
HANDLING AND STORAGE
Keep container tightly closed and dry and storage in cool place
Related News: The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.3353-69-3 The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.2-Butanone, 3-(2,3-dihydro-1H-indol-1-yl)- The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.2-fluoro-3-yodopiridina CAS:113975-22-7 It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.
Product Name | |
---|---|
clodronic acid Cas:10596-23-3 | View Details |
2-Chloronicotinic Acid Cas:2942-59-8 | View Details |
Ipragliflozin Cas:761423-87-4 | View Details |